Trial Profile
Clinical Study for Evaluating the Safety and Clinical Effectiveness of Intravitreal Bevacizumab (Lumiere) in Patients With Wet Age-related Macular Degeneration.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 May 2020
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Wet age-related macular degeneration
- Focus Adverse reactions; Registrational
- Sponsors Elea
- 20 Sep 2018 New trial record